389 related articles for article (PubMed ID: 28808759)
1. Life-threatening bleeding episodes in primary immune thrombocytopenia: a single-center retrospective study of 169 inpatients.
Tsuda H; Tsuji T; Tsuji M; Yamasaki H
Ann Hematol; 2017 Nov; 96(11):1915-1920. PubMed ID: 28808759
[TBL] [Abstract][Full Text] [Related]
2. Utility of the immature platelet fraction in pediatric immune thrombocytopenia: Differentiating from bone marrow failure and predicting bleeding risk.
McDonnell A; Bride KL; Lim D; Paessler M; Witmer CM; Lambert MP
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28921855
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for skin, mucosal, and organ bleeding in adults with primary ITP: a nationwide study in Japan.
Hato T; Shimada N; Kurata Y; Kuwana M; Fujimura K; Kashiwagi H; Takafuta T; Murata M; Tomiyama Y
Blood Adv; 2020 Apr; 4(8):1648-1655. PubMed ID: 32320469
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
Watts RG
Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
[TBL] [Abstract][Full Text] [Related]
5. Rate of bleeding-related episodes in elderly patients with primary immune thrombocytopenia: a retrospective cohort study.
Li S; Molony JT; Cetin K; Wasser JS; Altomare I
Curr Med Res Opin; 2018 Feb; 34(2):209-216. PubMed ID: 28748715
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults.
Piel-Julian ML; Mahévas M; Germain J; Languille L; Comont T; Lapeyre-Mestre M; Payrastre B; Beyne-Rauzy O; Michel M; Godeau B; Adoue D; Moulis G;
J Thromb Haemost; 2018 Sep; 16(9):1830-1842. PubMed ID: 29978544
[TBL] [Abstract][Full Text] [Related]
7. Acute immune thrombocytopenia (ITP) in childhood: retrospective and prospective survey in Germany.
Sutor AH; Harms A; Kaufmehl K
Semin Thromb Hemost; 2001 Jun; 27(3):253-67. PubMed ID: 11446659
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and predictors of treatment responses and complications in immune thrombocytopenia.
Ong SY; Tan CW; Ramya V; Malik AA; Lee XH; Hwang JCC; Yang Y; Ng HJ; Lee LH
Ann Hematol; 2021 Mar; 100(3):645-651. PubMed ID: 33515047
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors for resolution of childhood immune thrombocytopenia: Experience from a single tertiary center in Thailand.
Chotsampancharoen T; Sripornsawan P; Duangchoo S; Wongchanchailert M; McNeil E
Pediatr Blood Cancer; 2017 Jan; 64(1):128-134. PubMed ID: 27571705
[TBL] [Abstract][Full Text] [Related]
10. Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children: A prospective Nordic study of an unselected cohort.
Rosthøj S; Hedlund-Treutiger I; Rajantie J; Zeller B; Jonsson OG; Elinder G; Wesenberg F; Henter JI;
J Pediatr; 2003 Sep; 143(3):302-7. PubMed ID: 14517509
[TBL] [Abstract][Full Text] [Related]
11. Adult primary and secondary immune thrombocytopenic purpura: a comparative analysis of characteristics and clinical course.
Ayesh MH; Alawneh K; Khassawneh B; Khader Y; Kasasbeh A
Clin Appl Thromb Hemost; 2013 Jun; 19(3):327-30. PubMed ID: 22275396
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and outcome of immune thrombocytopenia in elderly: results from a single center case-controlled study.
Michel M; Rauzy OB; Thoraval FR; Languille L; Khellaf M; Bierling P; Godeau B
Am J Hematol; 2011 Dec; 86(12):980-4. PubMed ID: 21956157
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and Clinical Manifestations of Immune Thrombocytopenia.
Kohli R; Chaturvedi S
Hamostaseologie; 2019 Aug; 39(3):238-249. PubMed ID: 30868551
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study.
Palau J; Sancho E; Herrera M; Sánchez S; Mingot ME; Upegui RI; Rodríguez Salazar MJ; de la Cruz F; Fernández MC; González López TJ; Hernández JJ; Ríos E; López-Fernández MF; García M; Hernández JÁ; Sanz MA
Hematology; 2017 Sep; 22(8):484-492. PubMed ID: 28415913
[TBL] [Abstract][Full Text] [Related]
15. The incidence and clinical burden of immune thrombocytopenia in pediatric patients in the United States.
Shaw J; Kilpatrick K; Eisen M; Tarantino M
Platelets; 2020; 31(3):307-314. PubMed ID: 31271328
[TBL] [Abstract][Full Text] [Related]
16. A characteristic flow cytometric pattern with broad forward scatter and narrowed side scatter helps diagnose immune thrombocytopenia (ITP).
Araki R; Nishimura R; Kuroda R; Fujiki T; Mase S; Noguchi K; Ikawa Y; Maeba H; Yachie A
Int J Hematol; 2018 Aug; 108(2):151-160. PubMed ID: 29663189
[TBL] [Abstract][Full Text] [Related]
17. Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation.
Qu M; Liu Q; Zhao HG; Peng J; Ni H; Hou M; Jansen AJG
Ann Hematol; 2018 Sep; 97(9):1701-1706. PubMed ID: 29777278
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
[TBL] [Abstract][Full Text] [Related]
19. The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts.
Cohen YC; Djulbegovic B; Shamai-Lubovitz O; Mozes B
Arch Intern Med; 2000 Jun; 160(11):1630-8. PubMed ID: 10847256
[TBL] [Abstract][Full Text] [Related]
20. Comparative study between two bleeding grading systems of immune thrombocytopenia purpura.
Chen Q; Zhang Y; Li Y; Zhang L; Shi W; Tao H; Chen K; He Z; Wang C; Yu L
Hematology; 2021 Dec; 26(1):769-774. PubMed ID: 34565307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
